tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Dimerix Hits Phase 3 Recruitment Target for Lead Kidney Drug as FDA Backs Approval Pathway
Company AnnouncementsDimerix Hits Phase 3 Recruitment Target for Lead Kidney Drug as FDA Backs Approval Pathway
3d ago
DXB
Dimerix Strengthens Leadership with Appointment of New CFO and Company Secretary
PremiumCompany Announcements
Dimerix Strengthens Leadership with Appointment of New CFO and Company Secretary
11d ago
DXB
Dimerix Targets Investor and Partner Engagement at J.P. Morgan Healthcare Conference
PremiumCompany Announcements
Dimerix Targets Investor and Partner Engagement at J.P. Morgan Healthcare Conference
20d ago
DXB
Dimerix Gains FDA Endorsement of Key Endpoint for Phase 3 FSGS Trial
PremiumCompany Announcements
Dimerix Gains FDA Endorsement of Key Endpoint for Phase 3 FSGS Trial
1M ago
DXB
BioMarin’s US$4.8bn Amicus Deal Preserves Dimerix Licensing Rights and Bolsters Rare Kidney Drug Outlook
PremiumCompany Announcements
BioMarin’s US$4.8bn Amicus Deal Preserves Dimerix Licensing Rights and Bolsters Rare Kidney Drug Outlook
1M ago
DXB
Dimerix Completes Recruitment for ACTION3 Phase 3 Trial
PremiumCompany AnnouncementsDimerix Completes Recruitment for ACTION3 Phase 3 Trial
2M ago
DXB
Dimerix Limited Announces Director’s Interest Change
Premium
Company Announcements
Dimerix Limited Announces Director’s Interest Change
2M ago
DXB
Dimerix Limited Issues Unquoted Securities for Employee Incentive
Premium
Company Announcements
Dimerix Limited Issues Unquoted Securities for Employee Incentive
2M ago
DXB
Dimerix Achieves Positive IDMC Review for Phase 3 FSGS Trial
PremiumCompany Announcements
Dimerix Achieves Positive IDMC Review for Phase 3 FSGS Trial
2M ago
DXB
Dimerix Limited Successfully Passes All Resolutions at 2025 AGM
PremiumCompany Announcements
Dimerix Limited Successfully Passes All Resolutions at 2025 AGM
2M ago
DXB
Dimerix Advances Lead Program and Strengthens Commercial Strategy
PremiumCompany Announcements
Dimerix Advances Lead Program and Strengthens Commercial Strategy
2M ago
DXB
Dimerix Advances DMX-200 in Phase 3 Trials with Strong Financial Position
PremiumCompany Announcements
Dimerix Advances DMX-200 in Phase 3 Trials with Strong Financial Position
3M ago
DXB
Dimerix Limited Issues New Shares Following Option Exercise
PremiumCompany AnnouncementsDimerix Limited Issues New Shares Following Option Exercise
3M ago
DXB
Dimerix Limited Announces Quotation of New Securities on ASX
Premium
Company Announcements
Dimerix Limited Announces Quotation of New Securities on ASX
3M ago
DXB
Dimerix to Present Key Updates at Canaccord Drug & Device Conference 2025
Premium
Company Announcements
Dimerix to Present Key Updates at Canaccord Drug & Device Conference 2025
3M ago
DXB
Dimerix Limited Announces 2025 AGM Details
PremiumCompany Announcements
Dimerix Limited Announces 2025 AGM Details
4M ago
DXB
Dimerix Advances Kidney Disease Treatment with Positive PARASOL Data Analysis
PremiumCompany Announcements
Dimerix Advances Kidney Disease Treatment with Positive PARASOL Data Analysis
4M ago
DXB
Dimerix’s DMX-200 Gains Orphan Drug Status in Japan
PremiumCompany Announcements
Dimerix’s DMX-200 Gains Orphan Drug Status in Japan
4M ago
DXB
Dimerix Limited Announces 2025 Annual General Meeting Details
PremiumCompany Announcements
Dimerix Limited Announces 2025 Annual General Meeting Details
4M ago
DXB
Dimerix Limited Advances Kidney Disease Therapies Amid Industry Challenges
PremiumCompany AnnouncementsDimerix Limited Advances Kidney Disease Therapies Amid Industry Challenges
5M ago
DXB
Dimerix Limited Reports Significant Revenue Growth Despite Losses
Premium
Company Announcements
Dimerix Limited Reports Significant Revenue Growth Despite Losses
5M ago
DXB
Dimerix Unveils Progress on Phase 3 Asset for Rare Kidney Disease
Premium
Company Announcements
Dimerix Unveils Progress on Phase 3 Asset for Rare Kidney Disease
6M ago
DXB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >